Clinical Trials in Houston

Showing 12441-12460 of 15,366 trials

AR08 for Treatment of ADHD in Children

NCT01876719

This is a multicenter, multiple dose, randomized, double-blind, placebo-controlled, forced titration study. Patients will be randomized to 1 of 4 treatment groups in a 1:1:1:1 ratio. One-hundred twenty (120) patients are planned to be randomized. Each patient will receive AR08 (0.5, 1, or 2 mg per day) or matching placebo for seven (7) weeks.

ADHD

Arbor Pharmaceuticals, Inc.122 participantsStarted Jun 2013

Brandenton, Florida, United States • Jacksonville, Florida, United States • North Miami, Florida, United States +10 more locations

TERMINATEDPhase 2< 1 mile

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

NCT02049164

The purpose of this study is to determine the effective dose or dose range of AR08 in the treatment of VMS in menopausal females.

Vasomotor Symptoms (VMS)

Arbor Pharmaceuticals, Inc.32 participantsStarted Jan 2014

San Diego, California, United States • Colorado Springs, Colorado, United States • Colorado Springs, Colorado, United States +12 more locations

AR08 for Treatment of ADHD in Children

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Find Trials by Condition in Houston

Prehospital Resuscitation On Helicopter Study

Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Repair of Infected or Contaminated Hernias

Study of Asthma and Nasal Steroids

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma